Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Tumor combined treatment preparation with cell exosome loaded excitation reagent and photosensitizer and application thereof

A combined therapy and exosome technology, applied in the field of medical biology, to achieve the effect of avoiding infection and small drug resistance

Active Publication Date: 2021-11-02
THE SECOND PEOPLES HOSPITAL OF SHENZHEN
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] This application provides a tumor combination therapy preparation and its application of cellular exosomes loaded with stimulating reagents and photosensitizers, in order to solve the technical problem of how to design specific physiological characteristics of tumors and obtain a tumor preparation that does not require laser irradiation

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Tumor combined treatment preparation with cell exosome loaded excitation reagent and photosensitizer and application thereof
  • Tumor combined treatment preparation with cell exosome loaded excitation reagent and photosensitizer and application thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0036] In step (1), CCExosA is used as an example for the preparation of chemical dynamics and hypoxia linkage treatment preparation, and the preparation method is as follows:

[0037] 1) Separation and extraction of exosomes from M1 microglial cells. Mouse microglial cells BV2 were selected as the research object for culture, and a certain concentration of LPS was added to stimulate the production of M1 microglial cells. No exosomes were used in the whole process. The serum of exosomes was used for cell culture, and exosomes were extracted by ultracentrifugation. The method was as follows: Collect 40 mL of stimulated cell culture supernatant, 300 g, centrifuge at 4°C for 15 min, remove impurities and take the supernatant; 3 000 g, 4 Centrifuge at ℃ for 15 min, remove the cell debris and take the supernatant; centrifuge at 20 000g, 4℃ for 70 min, take the supernatant and filter it with a 0.22 μm sieve; Blot dry, exosomes contained in the pellet, resuspended with appropriate am...

Embodiment 1

[0043] Example 1. Separation and extraction of exosomes

[0044] After LPS (lipopolysaccharide) induction, the morphology of microglial cells changed significantly, showing an amoeba-like activated state, with enlarged cell bodies, retracted processes, and significant increases in pro-inflammatory factors such as TNF-α and IL-12, which manifested as M1 type microglia, and successfully isolated exosomes secreted by M1 type microglia. The toxicity of AQ4N to cells was explored, and it was found that 1 mg / mL of AQ4N had no obvious cytotoxicity after co-incubating with normal microglial cells for 48 h. figure 1 a PBS-treated BV2 was detected for microglial phenotype; figure 1 b is microglial phenotype detection of BV2 induced by LPS; figure 1 c is ELISA detection of TNF-α, IL-12, IL-10 polarizing cytokines; detection of M1 microglial cells; figure 1 d is the expression of related factors detected by RT-PCR, wherein iNOS and Arg1 are M1 markers; figure 1 e is the transmission e...

Embodiment 2

[0045] Example 2. In vivo application of M1-type Exosome regulation of tumor immune microenvironment and chemokinetic therapy preparation

[0046] Tumor-bearing mice were constructed, and CCExosA was injected into the tumor-bearing mice through the tail vein. CCExosA could pass through the BBB to reach the tumor site and be enriched in the tumor site. figure 2 a is the distribution of CCExosA across the BBB and in vivo, and the distribution in vivo over time; figure 2 b is the effect diagram of CCExosA increasing the expression of pro-inflammatory factors; figure 2 c is the change of M2 / M1 ratio in the tumor microenvironment, where M2 is M2 type microglia, M1 is M1 type microglia, and the M2 / M1 ratio in the PBS control group is higher than that of CCExosA, indicating that CCExosA can improve tumor microglia. The secretion of IL-12, IL-6, TNF-α and IFN-γ in the environment reduces the ratio of M2 microglia to M1 microglia in the tumor site, and CCExosA has the function of r...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of medical biology, in particular to a tumor combined treatment preparation with a cell exosome loaded excitation reagent and a photosensitizer and application thereof. The tumor combined treatment preparation is a carrier for loading an excitation reagent, a photosensitizer and a biological reducing drug in a glial cell exosome differentiated space, and the excitation reagent can excite the photosensitizer to react and emit light and is used for replacing laser; the biological reducing drug is loaded on glial cell exosomes and is used for penetrating deep tissues to perform immune microenvironment regulation and control. The tumor combined treatment preparation has no toxic or side effect on normal tissues, can penetrate through the blood-brain barrier (BBB), is small in drug resistance and cannot cause tumor cell metastasis.

Description

technical field [0001] The present application relates to the field of medical biotechnology, in particular to a tumor combination therapy preparation and its application loaded with exosomes stimulating reagent and photosensitizer. Background technique [0002] Due to the complexity, diversity and heterogeneity of glioma, it is difficult to completely treat glioma by using the immune microenvironment regulation function of exosomes. The combined use of multiple treatment modes can not only effectively overcome the disadvantages of a single treatment mode, but also give full play to the synergistic enhancement effect between multiple treatment modes. [0003] Microenvironment regulation and chemotherapy synergistically treat tumors: Since gliomas are solid malignant tumors, using exosomes alone to regulate the immune microenvironment has no advantage in the treatment of gliomas. Chemotherapy is currently a common method for the treatment of glioma, but even with the star ch...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K45/06A61K31/14A61K41/00A61K47/46A61P35/00C12N5/079
CPCA61K45/06A61K41/0061A61K41/0071A61K31/14A61K47/46A61P35/00C12N5/0622C12N2509/00
Inventor 王晓君丁辉聂国辉
Owner THE SECOND PEOPLES HOSPITAL OF SHENZHEN
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com